Table 2.
Comparison of left ventricular measures and whole-body atheroma burden between the groups
| No LGE | UMI | Non-specific LGE | P | |
|---|---|---|---|---|
| LVMa (g/m2) | 53.6 (26–109) | 64.1 (59–67) | 47.7 (40–60) | 0.08 |
| LVEDVa (mL/m2) | 70.5 (38–140) | 79.9 (72–96) | 69.6 (61–81) | 0.23 |
| LVESVa (mL/m2) | 21.7 (5–66) | 36.3 (27–61) | 19.9 (13–28) | 0.033 |
| LVSVa (mL/m2) | 48.3 (24–92) | 43.7 (35–45) | 49.7 (40–54) | 0.20 |
| LVEF (%) | 68.9 (38–89) | 54.7 (36–62) | 71.4 (65–78) | 0.019 |
| LVMVR (g/mL) | 0.76 (0.4–2.1) | 0.74 (0.7–0.9) | 0.70 (0.6–0.8) | 0.30 |
| SAS | 0 (0–19.6) | 4.2 (0–9) | 0 (0–2) | 0.27 |
LGE, late gadolinium enhancement; LVM, left ventricular mass; EDV, end diastolic volume; ESV, end-systolic volume; EF, ejection fraction; SV, stroke volume; LVMVR, left ventricular mass volume ratio; SAS, standardized atheroma score; UMI, unrecognized myocardial infarction.
aNormalized to body surface area.